Astal Laboratories share news, announcements and annual reports
BSE: 512600Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹63.07.
30 Oct: open ₹63.95, high ₹64.00, low ₹60.10
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹270 Cr2,455th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 27.77
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 0.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.15
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 12,192
Astal Laboratories share news and announcements
547 announcements, routine notices left out, newest first. Page 4 of 11.
Apr 2024
16 Apr · Compliance Certificate Under Reg. 40 (10) For The Year Ended 31St March 2024.
16 Apr · Compliance Certificate Under Reg. 7 (3) For The Year Ended 31St March 2024.
Feb 2024
9 Feb · Announcement under Regulation 30 (LODR)-Raising of Funds
2 Feb · Board meeting
Meeting on 9 Feb 2024: quarterly results
Jan 2024
Dec 2023
20 Dec · Announcement under Regulation 30 (LODR)-Raising of Funds
19 Dec · Announcement under Regulation 30 (LODR)-Change of Company Name
15 Dec · Board meeting
Meeting on 20 Dec 2023: increase in authorised capital and preferential issue of shares8 Dec · Board meeting
Meeting on 8 Dec 2023
Nov 2023
30 Nov · Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
3 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results
Oct 2023
13 Oct · Intimation Under Regulation 30
13 Oct · Board Comments.
13 Oct · Announcement under Regulation 30 (LODR)-Allotment
9 Oct · Board meeting
Meeting on 13 Oct 2023
Sep 2023
20 Sep · Management
20 Sep · Meeting
20 Sep · Results
Aug 2023
25 Aug · Reg. 34 (1) Annual Report.
19 Aug · Announcement under Regulation 30 (LODR)-Raising of Funds